- -

Humoral immune response to different routes of myxomatosis vaccine application

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Humoral immune response to different routes of myxomatosis vaccine application

Mostrar el registro sencillo del ítem

Ficheros en el ítem

Thumbnail
Nombre: 7021-38740-1-PB.pdf
Tamaño: 222.4Kb
Formato: PDF
Abrir
dc.contributor.author Manev, I. es_ES
dc.contributor.author Genova, K. es_ES
dc.contributor.author Lavazza, A. es_ES
dc.contributor.author Capucci, L. es_ES
dc.date.accessioned 2018-07-03T06:37:28Z
dc.date.available 2018-07-03T06:37:28Z
dc.date.issued 2018-06-28
dc.identifier.issn 1257-5011
dc.identifier.uri http://hdl.handle.net/10251/105082
dc.description.abstract [EN] The aim of our study was to monitor the dynamics of the serological response to different application routes of live attenuated myxomatosis vaccine. The study included 42 Californian breed rabbits, aged 3 mo, of both sexes. They were separated into 7 groups: 6 experimental and 1 control. All experimental groups were vaccinated on day 0 with a single dose of myxomatosis vaccine (min 103.3 tissue culture infective dose 50 [TCID50], max 105.8 TCID50). Three of the groups were injected with monovalent attenuated myxomatosis vaccine using different types of application: intradermal (i.d.), intramuscular (i.m.) and subcutaneous (s.c.). The other 3 groups were injected with bivalent attenuated vaccine against myxomatosis and rabbit haemorrhagic disease; again the routes of administration were i.d., i.m. and s.c.. There were no clinical signs or serious side effects after vaccination. The serological response was evaluated on days 7, 15 and 30 with a monoclonal antibody based-competition enzyme-linked immunosorbent assay (cELISA). More rapid and potent humoral response was detected in groups with i.d. inoculation in comparison to i.m. and s.c. routes. Vaccination with monovalent vaccine against myxomatosis induced higher antibody titre in comparison to bivalent vaccine. Our study showed that the vaccine application route and the type of vaccine used influence the speed and intensity of antibody response. es_ES
dc.language Inglés es_ES
dc.publisher Universitat Politècnica de València
dc.relation.ispartof World Rabbit Science
dc.rights Reserva de todos los derechos es_ES
dc.subject Myxoma virus es_ES
dc.subject Myxomatosis vaccination es_ES
dc.subject ELISA es_ES
dc.subject Antibody response es_ES
dc.title Humoral immune response to different routes of myxomatosis vaccine application es_ES
dc.type Artículo es_ES
dc.date.updated 2018-06-29T09:57:13Z
dc.identifier.doi 10.4995/wrs.2018.7021
dc.rights.accessRights Abierto es_ES
dc.description.bibliographicCitation Manev, I.; Genova, K.; Lavazza, A.; Capucci, L. (2018). Humoral immune response to different routes of myxomatosis vaccine application. World Rabbit Science. 26(2):149-154. https://doi.org/10.4995/wrs.2018.7021 es_ES
dc.description.accrualMethod SWORD es_ES
dc.relation.publisherversion https://doi.org/10.4995/wrs.2018.7021 es_ES
dc.description.upvformatpinicio 149 es_ES
dc.description.upvformatpfin 154 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 26
dc.description.issue 2
dc.identifier.eissn 1989-8886
dc.description.references Alfonso M., Pagès-Manté A. 2003. Serological response to Myxomatosis vaccination by different inoculation systems on farm rabbits. World Rabbit Sci. 2003, 11: 145-156. https://doi.org/10.4995/wrs.2003.504 es_ES
dc.description.references Barcena J., Morales M., Vázquez B., Boga J., Parra F., Lucientes J., Pagès-Manté A., Sánchez-Vizcaino J., Blasco R., Torres J. 2000. Horizontal Transmissible Protection against Myxomatosis and Rabbit Hemorrhagic Disease by Using a Recombinant Myxoma Virus. J. Virol., 74, 1114-1123. es_ES
dc.description.references Bertagnoli S., Gelfi J., Gall G., Boilletot E., Vautherot J., Rasschaert D., Laurent S., Petit F., Boucraut-Baralon C., Milon A. 1996. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. J. Virol., 70: 5061-5066. es_ES
dc.description.references Best S., Kerr P. 2000. Coevolution of Host and Virus: The Pathogenesis of Virulent and Attenuated Strains of Myxoma Virus in Resistant and Susceptible European Rabbits. Virology, 267, 36-48. https://doi.org/10.1006/viro.1999.0104 es_ES
dc.description.references Bhanuprakash V., Hosamani M., Venkatesan G., Balamurugan V., Yogisharadhya R., Singh R. 2012. Animal poxvirus vaccines: a comprehensive review Expert Rev. Vaccines, 11, 1355-1374. https://doi.org/10.1586/erv.12.116 es_ES
dc.description.references Calvete C., Estrada R., Lucientes J., Osacar J., Villafuerte R., 2004. Effects of vaccination against viral haemorrhagic disease (VHD) and myxomatosis on long-term mortality rates of European wild rabbits. Vet. Rec., 155: 388-392. es_ES
dc.description.references Dalton K., Nicieza I., Gullón J., Inza M., Petralanda M., Arroita Z., Parra F. 2012. Analysis of Myxomatosis outbreaks on Spanish rabbit farms. In Proc.: 10th World Rabbit Congress, September 3 - 6, 2012, Sharm El- Sheikh, Egypt, 1203-1207. es_ES
dc.description.references Dalton K., Nicieza I., de Llano D., Gullón J., Inza M., Petralanda M., Arroita Z., Parra F. 2015. Vaccine breaks: Outbreaks of myxomatosis on Spanish commercial rabbit farms. Vet. Microbiol., 178, 208-216. https://doi.org/10.1016/j.vetmic.2015.05.008 es_ES
dc.description.references Dan M., Baraitareanu S., Danes D., 2014. Serosurveillance of Myxomatosis by Competitive ELISA. Bulletin UASVM Veterinary Medicine. 71, 266-267. es_ES
dc.description.references Day M., Fenner F., Woodroofe G., McIntyre G.A. 1956. Further studies on the mechanism of mosquito transmission of Myxomatosis in the European rabbit. J. Hyg. Cambridge, 54:258-283. es_ES
dc.description.references Farsang A., Makranszki L., Dobos-Kovacs M., Virag G., Fabian K., Barna T., Kuclsar G., Kucsera L., Vetesi F. 2003. Occurrence of atypical myxomatosis in central Europe: clinical and virological examinations. Acta Vet. Hung., 51, 493-501. https://doi.org/10.1556/AVet.51.2003.4.7 es_ES
dc.description.references Fenner F., Ratcliffe F. 1965. Myxomatosis. Cambridge University Press, Cambridge, England. Ferreira C., Ramírez E., Castro F., Ferreras P., Alves P., Redpath S., Villafuerte R. 2009. Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild. Vaccine, 27: 6998-7002. https://doi.org/10.1016/j.vaccine.2009.09.075 es_ES
dc.description.references Jeklova E., Leva L., Matiasovic J., Kovarcik K., Kudlackova H., Nevorankova Z., Psikal I., Faldyna M. 2007. Characterisation of immunosuppression in rabbits after infection with myxoma virus, Vet. Microbiol., 129: 117-130. https://doi.org/10.1016/j.vetmic.2007.11.039 es_ES
dc.description.references Kerr P.J. 1997. An ELISA for Epidemiological Studies of Myxomatosis: Persistance of Antibodies to Myxoma Virus in European Rabbits (Oryctolagus cuniculus). Wildlife Res., 24: 53-65. es_ES
dc.description.references https://doi.org/10.1071/WR96058 es_ES
dc.description.references Kerr P.J. 2012. Myxomatosis in Australia and Europe: A model for emerging infectious diseases. Antivir. Res., 93: 387-415. https://doi.org/10.1016/j.antiviral.2012.01.009 es_ES
dc.description.references Kim, Y.C., Jarrahian, C., Zehrung, D., Mitragotri, S., Prausnitz , M.R. 2012. Delivery Systems for Intradermal Vaccination. Curr. Top. Microbiol., 351: 77-112. https://doi.org/10.1007/82_2011_123 es_ES
dc.description.references King A., Adams M., Carstens E., Lefkowitz E. 2012. Virus Taxonomy. Classification and Nomenclature of Viruses. Ninth Report of the International Committee on Taxonomy of Viruses, 291-309. es_ES
dc.description.references Lavazza A., Graziani M., Tranquillo V.M., Botti G., Palotta C., Cerioli M., Capucci L. 2004. Serorological evaluation of the immunity induced in commercial rabbits by vaccination for Myxomatosis and RHD, In Proc.: 8th World Rabbit Congress, September 7-10, 2004, Puebla, Mexico, 569-575. es_ES
dc.description.references Le Normand B., Chatellier S., Devaud I., Delvecchio A., Lavazza A., Capucci L. 2015. Evaluation de l'immunité humorale consécutive à la vaccination avec Dervaximyxo SG33 chez des lapines reproductrices vaccinées à différents stades du cycle productif. 16e Journées de la Recherche Cunicole. Le Mans, France. 17-20. es_ES
dc.description.references Lemiere S. 2000. Combined vaccination against myxomatosis and VHD: an innovative approach, In: 7th World Rabbit Congress, Valencia, 4-7th July, Spain, World Rabbit Sci., 8 suppl 1. Vol. B:289-297. es_ES
dc.description.references Levin C., Perrin H., Combadiere B. 2015. Tailored immunity by skin antigen-presenting cells. Hum. Vacc. Immunother., 11: 27-36. https://doi.org/10.4161/hv.34299 es_ES
dc.description.references Marlier D. 2010. Vaccination strategies against myxomavirus infections: are we really doing the best? Tijdschr Diergeneesk., 135: 194-198. es_ES
dc.description.references Marlier D., Mainil J., Boucraut-Baralon C., Linden A., Vindevogel H. 2000. The efficacy of two vaccination schemes against expérimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain. J. Comp. Path. Vol. 122, 115-122. https://doi.org/10.1053/jcpa.1999.0346 es_ES
dc.description.references Marshall I., Regnery C. 1960. Myxomatosis in a California brush rabbit (Sylvilagus bachmani). Nature, 188: 73-74. http://doi.org/10.1038/188073b0 es_ES
dc.description.references Morimoto M. 2009. General Physiology of Rabbits. In: Houdebine LM., Fan J. (eds) Rabbit Biotechnology. Springer, Dordrecht. OIE. 2014. Myxomatosis. Chapter 2.6.1. (NB: Version adopted in May 2014). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals http://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/2.06.01_MYXO.pdf Accessed June 2018. es_ES
dc.description.references Panchanathan V., Chaudhri G., Karupiah G. 2008. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol., 86, 80-86. https://doi.org/10.1038/sj.icb.7100118 es_ES
dc.description.references Rouco C, Moreno S, Santoro S. 2016. A case of low success of blind vaccination campaigns against myxomatosis and rabbit haemorrhagic disease on survival of adult European wild rabbits. Prev. Vet. Med., 133: 108-113. https://doi.org/10.1016/j.prevetmed.2016.09.013 es_ES
dc.description.references Spibey N., McCabe V., Greenwood N., Jack S., Sutton D., van der Waart L. 2012. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease. Vet. Rec., 170: 309. http://dx.doi.org/10.1136/vr.100366 es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem